1013 Cultivated cancer tissue slices as a meaningful preclinical model for evaluation of drug responsesI. Schonn, Kerstin A. David, Annika Sprüssel et al.|European Journal of Cancer Supplements|2009Cited by 0
Abstract C228: Preclinical analysis of therapeutic antibody efficiancy using an organoid model-based drug testing platform.Florian T. Unger, Kerstin A. David, Janina Schaller et al.|Molecular Cancer Therapeutics|2011Cited by 0